Revolutionizing Healthcare with AI: Innovative Strategies in Cancer Medicine
DOI:
https://doi.org/10.47709/ijmdsa.v3i1.3922Keywords:
Precision medicine, medical imaging, pathologic interpretation, genetic profiling, tailored treatment, artificial intelligence, oncology, cancer care, early detection, diagnosis, treatment planning, predictive analytics, and future directionsAbstract
By improving early detection, diagnosis, treatment planning, and patient management, artificial intelligence (AI) is transforming the way that cancer is treated. An overview of AI's function in cancer is given in this article, with special attention to how it advances precision medicine and improves patient outcomes. Numerous AI applications are discussed, such as predictive analytics, pathology interpretation, genetic profiling, and medical imaging analysis. Case studies highlight effective AI applications in cancer care, showcasing the technology's effectiveness in enhancing the precision of diagnoses, directing individualized treatment choices, and tracking treatment response. The paper delves into the possible advancements in early identification, therapy optimization, and patient engagement through an exploration of future directions and innovations in AI-driven oncology research. The conclusion emphasizes how AI has the ability to completely change the way cancer is treated and enhance the lives of cancer sufferers all over the world.
References
Lee, E. (2021). How do we build trust in machine learning models? Available at SSRN 3822437.
Lip, S., Visweswaran, S., & Padmanabhan, S. (2020). Transforming Clinical Trials with Artificial Intelligence.
In Artificial Intelligence (pp. 297–306). Productivity Press.
Luengo-Oroz, M., Pham, K. H., Bullock, J., Kirkpatrick, R., Luccioni, A., Rubel, S., Wachholz, C., Chakchouk,
M., Biggs, P., & Nguyen, T. (2020). Artificial intelligence cooperation to support the global response to COVID-
Nature Machine Intelligence, 2(6), 295–297.
Maphumulo, W. T., & Bhengu, B. R. (2019). Challenges of quality improvement in the healthcare of South
Africa post-apartheid: A critical review. Curationis, 42(1), 1–9.
Mayorga-Ruiz, I., Jiménez-Pastor, A., Fos-Guarinos, B., López-González, R., García-Castro, F., & Alberich-
Bayarri, Á. (2019). The Role of AI in Clinical Trials. In Artificial cite this version: Shaheen, M. Y. (2021).
Applications of Artificial Intelligence (AI) in healthcare: A review. 8 Intelligence in Medical Imaging (pp. 231–
. Springer.
McNeill, P. M., & Walton, M. (2002). Medical harm and the consequences of error for doctors. The Medical
Journal of Australia, 176(5), 222–225.
Pavli, A., Theodoridou, M., & Maltezou, H. C. (2021). Post-COVID syndrome: Incidence, clinical spectrum,
and challenges for primary healthcare professionals. Archives of Medical Research.
Prabu, A. (2021). SmartScope: An AI-Powered Digital Auscultation Device to Detect Cardiopulmonary
Diseases.
Ross, S., Bond, C., Rothnie, H., Thomas, S., & Macleod, M. J. (2009). What is the scale of prescribing errors
committed by junior doctors? A systematic review. British Journal of Clinical Pharmacology, 67(6), 629–640.
Shi, D., Zhang, W., Zhang, W., & Ding, X. (2019). A review on lower limb rehabilitation exoskeleton robots.
Chinese Journal of Mechanical Engineering, 32(1), 1–11.
Sucharitha, G., & Chary, D. V. (2021). Predicting the effect of Covid-19 by using artificial intelligence: A case
study. Materials Today: Proceedings.
Ting, D. S. W., Liu, Y., Burlina, P., Xu, X., Bressler, N. M., & Wong, T. Y. (2018). AI for medical imaging
goes deep. Nature Medicine, 24(5), 539–540.
Vaishya, R., Javaid, M., Khan, I. H., & Haleem, A. (2020). Artificial Intelligence (AI) applications for COVID-
pandemic. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(4), 337–339.
Van der Schaar, M., Alaa, A. M., Floto, A., Gimson, A., Scholtes, S., Wood, A., McKinney, E., Jarrett, D., Lio,
P., & Ercole, A. (2021). How artificial intelligence and machine learning can help healthcare systems respond
to COVID-19. Machine Learning, 110(1), 1–14.
Woo, M. (2019). An AI boost for clinical trials. Nature, 573(7775), S100–S100
Undru TR, Uday U, Lakshmi JT, et al. Integrating Artificial Intelligence for Clini- cal and Laboratory diagnosis
- a review. Maedica (Bucur). 2022; 17(2):420–6. https://doi.org/10.26574/maedica.2022.17.2.420. Page 13 of
Alowais et al. BMC Medical Education (2023) 23:689
Peiffer-Smadja N, Dellière S, Rodriguez C, Birgand G, Lescure FX, Fourati S et al. Machine learning in the
clinical microbiology laboratory: has the time come for routine practice? Clin Microbiol Infect. 2020;
(10):1300–9. https://doi.org/10.1016/j.cmi.2020.02.006
Smith KP, Kang AD, Kirby JE. Automated interpretation of Blood Culture Gram Stains by Use of a deep
convolutional neural network. J Clin Microbiol. 2018; 56(3):e01521–17. https://doi.org/10.1128/JCM.01521-
Weis CV, Jutzeler CR, Borgwardt K. Machine learning for microbial identifica-tion and antimicrobial
susceptibility testing on MALDI-TOF mass spectra: a systematic review. Clin Microbiol Infect. 2020;
(10):1310–7. https://doi.org/10.1016/j.cmi.2020.03.014.
Go T, Kim JH, Byeon H, Lee SJ. Machine learning-based in-line holographic sensing of unstained malaria-
infected red blood cells. J Biophotonics. 2018; 11(9):e201800101. https://doi.org/10.1002/jbio.201800101.
Smith KP, Kirby JE. Image analysis and artificial intelligence in infectious disease diagnostics. Clin Microbiol
Infect. 2020; 26(10):1318–23. https://doi.org/10.1016/j.cmi.2020.03.012.
Vandenberg O, Durand G, Hallin M, Diefenbach A, Gant V, Murray P, et al. Consolidation of clinical
Microbiology Laboratories and introduction of Transformative Technologies. Clin Microbiol Rev. 2020; 33(2).
https://doi.org/10.1128/cmr.00057-19.
Panch T, Szolovits P, Atun R. Artificial Intelligence, Machine Learning and Health Systems. J Global Health.
; 8(2). https://doi.org/10.7189/jogh.08.020303
Berlyand Y, Raja AS, Dorner SC, Prabhakar AM, Sonis JD, Gottumukkala RV, et al. How artificial intelligence
could transform emergency department operations. Am J Emerg Med. 2018; 36(8):1515–7.
https://doi.org/10.1016/j.ajem.2018.01.017.
Matheny ME, Whicher D, Thadaney Israni S. Artificial Intelligence in Health Care: a Report from the National
Academy of Medicine. JAMA. 2020; 323(6):509–10. https://doi.org/10.1001/jama.2019.21579.
Jiang F, Jiang Y, Zhi H, Dong Y, Li H, Ma S, et al. Artificial intelligence in health- care: past, present and future.
Stroke Vasc Neurol. 2017; 2(4):230–43. https://doi.org/10.1136/svn-2017-000101.
Gandhi SO, Sabik L. Emergency department visit classification using the NYU algorithm. Am J Manag Care.
; 20(4):315–20.
Hautz WE, Kämmer JE, Hautz SC, Sauter TC, Zwaan L, Exadaktylos AK, et al. Diagnostic error increases
mortality and length of hospital stay in patients presenting through the emergency room. Scand J Trauma Resusc
EmergMed. 2019; 27(1):54. https://doi.org/10.1186/s13049-019-0629-z.
Haug CJ, Drazen JM. Artificial Intelligence and Machine Learning in Clinical Medicine, 2023. N Engl J Med.
; 388(13):1201–8. https://doi.org/10.1056/NEJMra2302038.
Abubaker Bagabir S, Ibrahim NK, Abubaker Bagabir H, Hashem Ateeq R. Covid-19 and Artificial Intelligence:
genome sequencing, drug development and vaccine discovery. J Infect Public Health. 2022; 15(2):289–96.
https://doi.org/10.1016/j.jiph.2022.01.011.
Pudjihartono N, Fadason T, Kempa-Liehr AW, O’Sullivan JM. A review of fea-ture selection methods for
machine learning-based Disease Risk Prediction. Front Bioinform. 2022; 2:927312.
https://doi.org/10.3389/fbinf.2022.927312. Published 2022 Jun 27.
Widen E, Raben TG, Lello L, Hsu SDH. Machine learning prediction of bio-markers from SNPs and of Disease
risk from biomarkers in the UK Biobank. Genes (Basel). 2021; 12(7):991.
https://doi.org/10.3390/genes12070991. Published 2021 Jun 29.
Wang H, Avillach P. Diagnostic classification and prognostic prediction using common genetic variants in
autism spectrum disorder: genotype-based Deep Learning. JMIR Med Inf. 2021; 9(4).
https://doi.org/10.2196/24754.
Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expres-sion patterns of breast
carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci. 2001; 98:10869–74.
https://doi.org/10.1073/pnas.191367098.
Jamal, A. (2023). Novel Approaches in the Field of Cancer Medicine. Biological times, 2(12), 52-53.
Yersal O. Biological subtypes of breast cancer: prognostic and therapeutic implications. World J Clin Oncol.
; 5(3):412–24. https://doi.org/10.5306/wjco.v5.i3.412.
eek JT, Scharpf RB, Bravo HC, Simcha D, Langmead B, Johnson WE, et al. Tack-ling the widespread and
critical impact of batch effects in high-throughputdata. Nat Rev Genet. 2010; 11:733–9.
https://doi.org/10.1038/nrg2825.
Blanco-González A, Cabezón A, Seco-González A, Conde-Torres D, Antelo-Riveiro P, Piñeiro Á, et al. The role
of AI in drug discovery: Challenges, opportunities, and strategies. Pharmaceuticals. 2023; 16(6):891.
https://doi.org/10.3390/ph16060891.
Tran TTV, Surya Wibowo A, Tayara H, Chong KT. Artificial Intelligence in Drug Toxicity Prediction: recent
advances, Challenges, and future perspec-tives. J Chem Inf Model. 2023; 63(9):2628–43.
https://doi.org/10.1021/acs. jcim.3c00200
Tran TTV, Tayara H, Chong KT. Artificial Intelligence in Drug Metabo-lism and Excretion Prediction: recent
advances, Challenges, and future perspectives. Pharmaceutics. 2023; 15(4):1260. https://doi.org/10.3390/
pharmaceutics15041260
Guedj M, Swindle J, Hamon A, Hubert S, Desvaux E, and Laplume J, et al. Indus-trializing AI-powered drug
discovery: Lessons learned from the patrimony computing platform. Expert Opin Drug Discov. 2022; 17(8):815–
https://doi.org/10.1080/17460441.2022.2095368.
Ahmed F, Kang IS, Kim KH, Asif A, Rahim CS, Samantasinghar A, et al. Drug repurposing for viral cancers: a
paradigm of machine learning, Deep Learn-ing, and virtual screening-based approaches. J Med Virol. 2023;
(4). https://doi.org/10.1002/jmv.28693.
Singh DP, Kaushik B. A systematic literature review for the prediction of anticancer drug response using various
machine-learning and deep- learning techniques. Chem Biol Drug Des. 2023; 101(1):175–94.
https://doi.org/10.1111/cbdd.14164.
Quazi S. Artificial intelligence and machine learning in precision and genomic medicine. Med Oncol. 2022;
(2):120. https://doi.org/10.1007/s12032-022-01711-1.
Subramanian M, Wojtusciszyn A, Favre L, Boughorbel S, Shan J, Letaief KB, et al. Precision medicine in the
era of artificial intelligence: implications in chronic disease management. J Transl Med. 2020; 18(1):472.
https://doi.org/10.1186/s12967-020-02658-5.
Johnson KB, Wei WQ, Weeraratne D, Frisse ME, Misulis K, Rhee K, et al. Preci-sion Medicine, AI, and the
future of Personalized Health Care. Clin Transl Sci.2021; 14(1):86–93. https://doi.org/10.1111/cts.12884.
Pulley JM, Denny JC, Peterson JF, Bernard GR, Vnencak-Jones CL, Ramirez AH,et al. Operational
implementation of prospective genotyping for personal- ized medicine: the design of the Vanderbilt PREDICT
project. Clin PharmacolTher. 2012; 92(1):87–95. https://doi.org/10.1038/clpt.2011.371.
Huang C, Clayton EA, Matyunina LV, McDonald LD, Benigno BB, Vannberg F, et al. Machine learning predicts
individual cancer patient responses to therapeutic drugs with high accuracy. Sci Rep. 2018; 8(1):16444.
https://doi.org/10.1038/s41598-018-34753-5.
Sheu YH, Magdamo C, Miller M, Das S, Blacker D, Smoller JW. AI-assisted prediction of differential response
to antidepressant classes using elec-tronic health records. npj Digit Med. 2023;6:73.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Murad Khan, Ashish Shiwlani, Ashish Shiwlani, Muhammad Umer Qayyum, Abdul Mannan Khan Sherani, Hafiz Khawar Hussain
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
